Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial
Authors:
- José Luis TovarJTJosé Luis Tovar
- Gabriel SampolGSGabriel Sampol
- Odile RomeroOROdile Romero
- María José JuradoMJMaría José Jurado
- Alfons SegarraASAlfons Segarra
- Eugènia EspinelEEEugènia Espinel
- José RíosJRJosé Ríos
- María Dolores UntoriaMUMaría Dolores Untoria
- Patrícia LloberesPLPatrícia Lloberes
- 1 October 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 28 (10) , 2161-2168
Abstract
This controlled trial assessed the effect of continuous positive airway pressure (CPAP) on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH). We evaluated 96 patients with resistant hypertension, defined as clinic BP at least 140/90 mmHg despite treatment with at least three drugs at adequate doses, including a diuretic. Patients underwent a polysomnography and a 24-h ambulatory BP monitoring (ABPM). They were classified as consulting room or ABPM-confirmed resistant hypertension, according to 24-h BP lower or higher than 125/80 mmHg. Patients with an apnea-hypopnea index at least 15 events/h (n = 75) were randomized to receive either CPAP added to conventional treatment (n = 38) or conventional medical treatment alone (n = 37). ABPM was repeated at 3 months. The main outcome was the change in systolic and diastolic BP. Sixty-four patients completed the follow-up. Patients with ABPM-confirmed resistant hypertension treated with CPAP (n = 20), unlike those treated with conventional treatment (n = 21), showed a decrease in 24-h diastolic BP (-4.9 ± 6.4 vs. 0.1 ± 7.3 mmHg, P = 0.027). Patients who used CPAP > 5.8 h showed a greater reduction in daytime diastolic BP {-6.12 mmHg [confidence interval (CI) -1.45; -10.82], P = 0.004}, 24-h diastolic BP (-6.98 mmHg [CI -1.86; -12.1], P = 0.009) and 24-h systolic BP (-9.71 mmHg [CI -0.20; -19.22], P = 0.046). The number of patients with a dipping pattern significantly increased in the CPAP group (51.7% vs. 24.1%, P = 0.008). In patients with resistant hypertension and OSA, CPAP treatment for 3 months achieves reductions in 24-h BP. This effect is seen in patients with ABPM-confirmed resistant hypertension who use CPAP more than 5.8 h.Keywords
This publication has 35 references indexed in Scilit:
- Obstructive sleep apnoea and its cardiovascular consequencesThe Lancet, 2009
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Randomized Placebo-controlled Trial of Continuous Positive Airway Pressure on Blood Pressure in the Sleep Apnea–Hypopnea SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Association of Hypertension and Sleep-Disordered BreathingArchives of internal medicine (1960), 2000
- Prospective Study of the Association between Sleep-Disordered Breathing and HypertensionNew England Journal of Medicine, 2000
- Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community-Based StudyJAMA, 2000
- Obstructive sleep apnoea syndrome as a risk factor for hypertension: population studyBMJ, 2000
- Effect of Continuous Positive Airway Pressure on Blood PressureHypertension, 2000
- Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model.Journal of Clinical Investigation, 1997
- Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats.Hypertension, 1992